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Background and Objectives: Recent studies have described direct reprogramming of mouse and human somatic cells 
into induced neural stem cells (iNSCs) using various combinations of transcription factors. Although iNSC technology 
holds a great potential for clinical applications, the low conversion efficiency and limited reproducibility of iNSC gen-
eration hinder its further translation into the clinic, strongly suggesting the necessity of highly reproducible method 
for human iNSCs (hiNSCs). Thus, in orderto develop a highly efficient and reproducible protocol for hiNSC generation, 
we revisited the reprogramming potentials of previously reported hiNSC reprogramming cocktails by comparing the 
reprogramming efficiency of distinct factor combinations including ours.
Methods: We introduced distinct factor combinations, OSKM (OCT4+SOX2+KLF4+C-MYC), OCT4 alone, SOX2 
alone, SOX2+HMGA2, BRN4+SKM+SV40LT (BSKMLT), SKLT, SMLT, and SKMLT and performed comparative analy-
sis of reprogramming potentials of distinct factor combinations in hiNSC generation.
Results: Here we show that ectopic expression of five reprogramming factors, BSKMLT leads the robust hiNSC gen-
eration (>80 folds enhanced efficiency) from human somatic cells compared with previously described factor 
combinations. With our combination, we were able to observe hiNSC conversion within 7 days of transduction. 
Throughout further optimization steps, we found that both BRN4 and KLF4 are not essential for hiNSC conversion.
Conclusions: Our factor combination could robustly and reproducibly generate hiNSCs from human somatic cells with 
distinct origins. Therefore, our novel reprogramming strategy might serve as a useful tool for hiNSC-based clinical 
application.
Keywords: Direct conversion, Human induced neural stem cells, Robust and reproducible generation, Defined factors
Tae Hwan Kwak, et al: Robust and Reproducible Generation of Induced Neural Stem Cells from Human Somatic Cells by Defined Factors  81
Introduction 
  Neural stem cells (NSCs), one of somatic stem cell 
types, can differentiate into various types of neurons and 
glial cells of the central nervous system (CNS) in response 
to distinct signaling cues (1) and their transplantation 
could reverse the pathophysiology of CNS disorders in an-
imal models (2). Thus, NSCs have long been considered 
as a highly suitable cell source for restoring damaged 
nerve tissues in various neurodegenerative diseases (3, 4). 
Despite the clinical potentials of the brain tissue-derived 
NSCs, their limited accessibility and the potential risk of 
immune rejection upon allogeneic transplantation may 
preclude their clinical application. Recent induced pluri-
potent stem cell (iPSC) technology (5) open a new avenue 
of patient-specific clinical applications such as cell re-
placement therapy. Since iPSCs are equivalent to embry-
onic stem cells (ESCs) in their self-renewal capacity as 
well as their pluripotency, they have been considered as 
an alternative cell source for transplantable patient-specif-
ic NSCs. However, there are also some roadblocks of 
iPSC-based cell therapy such as the potential risk of tu-
mor formation upon transplantation due to the residual 
undifferentiated pluripotent stem cells even after long dif-
ferentiation steps.
  Alternatively, ectopic expression of cell type–specific 
genes could lead a direct cell fate transition from a so-
matic cell state into completely distinct cellular identities 
without first generating iPSCs (6-12). This direct con-
version technology could also be a useful tool to generate 
patient-specific NSCs which are non-tumorigenic (10, 13, 
14). Some previous studies have used the forced ex-
pression of the Yamanaka’s reprogramming factors, OCT4, 
SOX2, KLF4, and C-MYC (OSKM), to convert somatic 
cells into human induced neural stem cells (hiNSCs) with 
a combined treatment of small molecules which can facili-
tate the reprogramming procedure (15, 16). However, the 
iNSC conversion process using OSKM could involve a 
transiently acquired pluripotent state, suggesting the po-
tential risk of tumor formation using this reprogramming 
strategy (17). In other cases of hiNSC generation, re-
programming could be achieved by overexpression of a 
single transcription factor (18-20) or a combination of cell 
type-specific genes (21). Those directly reprogrammed 
hiNSCs are non-tumorigenic upon transplantation to the 
animal model (18-20). Nevertheless, the extremely low ef-
ficiency as well as unclear reproducibility of iNSC gen-
eration have been remained as a major roadblock of 
hiNSC technology (15, 19, 21, 22).
  Previously we have also described the generation of 
iNSCs from mouse fibroblasts through the ectopic ex-
pression of NSC-specific transcription factors, Brn4, Sox2, 
Klf4, and c-Myc (BSKM) (10, 11). The directly converted 
iNSCs are nearly indistinguishable from the brain tis-
sue-derived NSCs in their morphology, gene expression 
patterns, epigenetic status, self-renewal capacity, and both 
in vitro and in vivo multipotency (10, 11, 14, 23). More-
over, iNSC could ameliorate the disease phenotypes upon 
transplantation into animal models without forming tu-
mor, showing their therapeutic potentials for CNS dis-
eases (14, 24). More importantly, we recently demon-
strated that the BSKM-mediated iNSC generation is a di-
rect process that does not involve an intermediate pluri-
potent state (25), indicating that BSKM may be a highly 
reliable and safe reprogramming factor combination for 
generating transplantable hiNSCs. However, the re-
programming capacity of BSKM in human cells has yet 
to be determined (26).
  In the current study, we have established an efficient 
and reproducible method for generating hiNSCs using fi-
broblasts from multiple origins by introducing a defined 
and optimized set of reprogramming factors, resulting in 
a robust hiNSC conversion within 7 days of transduction. 
The transdifferentiated hiNSCs exhibited typical features 
of NSCs such as morphology, gene expression patterns, 
and differentiation capacity. Our robust and reproducible 
reprogramming strategy for hiNSC generation may facili-
tates hiNSC-based clinical translation. 
Materials and Methods
Cell culture
  Human fibroblasts maintained in DMEM with high 
glucose (Welgene) containing 10% fetal bovine serum 
(Seradigm), 1× MEM/NEAA (Gibco), and 1× penicillin/ 
streptomycin/glutamine (Gibco). The ESC-derived NSCs 
were maintained in DMEM/F12 (Corning) supplemented 
with 100× N2 supplement (Gibco), 50× B27 without vita-
min A (Gibco), 1% penicillin/streptomycin (PS) (Gibco), 
1% GlutaMAX (Gibco), 55 μM β-mercaptoethanol (Gibco), 
0.05% Bovine serum albumin fraction V (Invitrogen), 10 
ng/ml leukemia inhibitory factor, 3 μM CHIR99021 (To-
cris), and 2 μM SB431542 (Sigma). hiNSCs were gen-
erated and maintained in neural stem cell expansion me-
dium (NSCEM), composed of ReNcell NSC Maintenance 
Medium (Merck) supplemented with 20 ng/ml bFGF 
(Peprotech), 20 ng/ml EGF (Peprotech), 0.5 μM phor-
bol-12-myristate-13-acetate (Sigma), 3 μM CHIR99021 
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(Tocris), and 2 μM SB431542 (Sigma). The H9 hESCs 
were maintained in TeSRTM-E8TM medium (STEMCELL 
Technologies) and subcultured using the ReLeSRTM 
(STEMCELL Technologies) according to the manufac-
turer’s instructions. Differentiation of hESC into NSCs 
was performed as previously described (27). Briefly, 
hESCs were detached by ReleSRTM (STEMCELL Tech-
nologies) to form the Embryoid bodies (EBs) and EBs 
were cultured in the neural induction medium (NIM) con-
taining DMEM/F12 (Corning) supplemented with 1x N2 
(Gibco), 1× B27 without vitamin A (Gibco), 1% pen-
icillin/streptomycin (Gibco), 1% GlutaMAXTM (Gibco), 
1% NEAA (Gibco), 55 μM β-mercaptoethanol (Gibco) in 
the presence of 3 μM CHIR99021, 2 μM SB431542 and 
10 ng/ml hLIF (Millipore). After 7 days, the EBs were dis-
sociated into single cells using TrypLETM (Gibco) and 
re-plated on the Matrigel (Corning)-coated surfaces. The 
hESC-derived NSCs were stabilized in NIM by serial 
passaging.
Retrovirus production
  Retroviral particles were produced by transfection of 
pMX vectors encoding reprogramming factors (10 μg) in-
to Platinum E cells (Cell Biolabs) using 30 μl of jetPEI 
transfection reagent (Polyplus). After 48 hrs, the super-
natants containing viral particles were carefully collected 
and filtered through a 0.22-μm syringe filter (Minisart).
Generation of hiNSCs
  To generate hiNSCs, 5×104 human fibroblasts were 
plated onto a gelatin-coated 35 mm dish. Next day, fibro-
blasts were transduced with retroviral particles encoding 
a reprogramming factor combination using 6 μg/ml prot-
amine sulfate (Sigma), re-plated onto a Matrigel (Corning)- 
coated 35 mm dish and cultured in NSCEM, which was 
replaced with fresh medium every other day. Once the ini-
tial colonies were observed, stable hiNSC lines were estab-
lished by serial passaging. For the comparative analysis of 
reprogramming potentials of distinct factor combinations 
in hiNSC generation, we used the identical conditions 
from previous studies for each reprogramming cocktails, 
OSKM (15), OCT4 (19), SOX2 (18), and SOX2＋HMGA2 
(21).
Gene expression analysis
  Total RNA was isolated by using a Hybrid-RTM RNA 
isolation kit (GeneAll) according to the manufacturer’s 
protocol. RNA (1 μg) was converted to cDNA using a 
High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). RT-PCR was performed using GoTag Green 
Master Mix (Promega). qPCR was performed using SYBR 
Green PCR Master Mix (Applied Biosystems) on a 
QuantStudio 3 Real-Time PCR instrument (Applied Bio-
systems). ΔCt values were calculated by subtracting the 
GAPDH Ct value from that of each target gene. Relative 
expression levels were calculated by using the 2−ΔΔCt 
method. The primer sets are listed in Supplementary 
Table S1.
RNA sequencing analysis
  Quality of the RNA-seq raw reads were assessed with 
Fastqc (0.11.8) and the reads were aligned with STAR 
(v2.6.1a) on UCSC hg38 human genome. Gene expression 
level was calculated and normalized with Cuffnorm 
(v2.2.1, Cufflinks). Genes with more than two-fold differ-
ence of expression levels between hFFs and hESC-derived 
NSCs and FPKM value of more than 2 were chosen to 
generate the heatmap. Selected genes were sorted to be 
clustered into different groups of up-regulated or down- 
regulated genes compared to hESC-derived NSCs. Data 
visualization was conducted with heatmap.2 function of R 
package gplots (v3.0.1.1).
Immunocytochemistry
  Cells were fixed with 4% paraformaldehyde (Chemcruz) 
for 15 min at room temperature, and then washed three 
times with PBS (Life Genomics). After washing, the fixed 
cells were permeabilized and blocked with PBS containing 
0.03% Triton X-100 (Sigma) and 6% BSA (Sigma) for 1 
hr at room temperature. The following primary antibodies 
were used: goat anti-SOX2 (Santa Cruz, 1：200), goat anti 
BRN2 (Santa Cruz, 1：200), rabbit anti-BLBP (Santa 
Cruz, 1：200), rat anti-MSI1 (MBL, 1：200), rabbit an-
ti-MSI2 (Abcam, 1：200), mouse anti-TUJ1 (Covance, 1：
500), rabbit anti-GFAP (Dako, 1：500), mouse anti-MBP 
(Abcam, 1：500), rabbit anti-GABA (Sigma, 1：200), rab-
bit anti-GLU (Sigma, 1：200), goat-anti ChAT (Merck, 
1：200), and rabbit anti-TH (Merck, 1：200)，and rabbit 
anti-MBP (Abcam, 1：200). Permeabilized cells were in-
cubated with primary antibodies for 16 hrs at 4℃, washed 
three times with PBS, and incubated with secondary anti-
bodies for 2 hrs at room temperature. Counterstaining was 
performed with Hoechst 33342 (Sigma).
In vitro differentiation of NSCs
  To differentiate hiNSCs and hESC-derived NSCs into 
neurons, the cells were dissociated into single cells and 
1×104 cells were plated onto Matrigel-coated single well 
of 4-well plate. After 24 hrs, the medium was replaced 
with a 1：1 mix of DMEM/F12 (Corning) and Neurobasal 
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Medium (Gibco) supplemented with 100× N2 supplement 
(Gibco), 50× B27 (Gibco), 1% PS (Gibco), 1% GlutaMAX 
(Gibco), 1% NEAA (Gibco), 55 μM β-mercaptoethanol 
(Gibco), 1 μg/ml heparin (Sigma), 10 ng/ml BDNF 
(Peprotech), 10 ng/ml GDNF (Peprotech), 200 μM ascor-
bic acid (Peprotech), and 125 μM cAMP (Peprotech). To 
differentiate hiNSCs and hESC-derived NSCs into as-
trocytes, the cells were dissociated and plated as above. 
After 24 hrs, the medium was replaced with DMEM/F12 
(Corning) supplemented with 100× N2 supplement 
(Gibco), 50× B27 (Gibco), 1% PS (Gibco), 1% GlutaMAX 
(Gibco), 1% NEAA (Gibco), 10 ng/ml BMP4 (Peprotech), 
and 20 ng/ml CNTF (Peprotech). Two weeks after induc-
ing differentiation, the neurons and astrocytes were im-
munostained with antibody against TUJ1 and GFAP, 
respectively. The subtypes of neurons were determined at 
5 weeks after inducing differentiation. 
Statistical analysis
  All information related to statistical tests is documented 
in the corresponding figure legends and in the supple-
mentary figure legends. Data are reported as mean values 
from at least three replicates, with error bars denoting SD. 
Statistical significance was evaluated with unpaired two- 
tailed Student’s t-test.
Results 
Robust and reproducible generation of hiNSCs
  During the early phase of reprogramming, an enhanced 
proliferation rate of somatic cells has been shown to be 
critical for achieving improved reprogramming efficiency 
(28, 29). This prompted us to hypothesize that the addi-
tion of NSC-specific mitogens which can activate cell cycle 
may elevate the direct conversion efficiency toward NSCs. 
To this end, the human fetal fibroblasts (hFFs) trans-
duced with BSKM (10, 11) were cultured in neural stem 
cell expansion medium (NSCEM) supplemented with 
EGF and bFGF and three additional small molecules; 
phorbol-12-myristate-13-acetate, CHIR99021, and SB431542, 
which are all known to activate a mitotic pathway in ear-
ly-stage progenitors of the neuroectoderm (30, 31) (Fig. 
1A). However, BSKM-transduced hFFs did not show any 
morphological changes until 4 weeks after viral infection. 
Most of the transduced hFFs maintained their typical fi-
broblast morphology with a slow proliferation rate and 
eventually underwent cellular senescence (data not shown). 
This finding suggests that BSKM is not sufficient to con-
vert human fibroblasts into an NSC-like state.
  Previous studies declaimed that the forced expression of 
SV40 large T antigen (SV40LT) significantly enhances the 
reprogramming efficiency of human iPSCs by improving 
cell proliferation rates and also by reducing cellular apop-
tosis (32). Additional SV40LT could also facilitate the 
transdifferentiation and expansion of human induced hep-
atocytes (12). Thus, to improve the conversion efficiency 
of hiNSCs, we introduced the SV40LT into hFFs together 
with BSKM (Fig. 1A). After 7 days of viral infection, we 
found the initial iNSC clusters with typical epithelial 
morphology and higher proliferation capacity compared 
with those of unreprogrammed hFFs (12.25±9.56 colonies 
per individual experimental group) (Fig. 1A). At 2 weeks 
of transduction, a NSC-like cell population with homoge-
nous morphology were observed and they could be stably 
expanded along the serial passaging (Fig. 1B and 1C). A 
subset of NSC markers started to be expressed in estab-
lished hiNSCs (passage 1) with complete suppression of 
hFF markers and became strongly activated upon further 
passaging (passage 10) (Fig. 1D), indicating the gradual 
reprogramming process of hiNSCs as in mouse case (10, 
11). Similarly, hiNSCs generated with BSKM and SV40LT 
exhibited the gradual morphological changes during fur-
ther passaging, i.e., less defined shapes in early passage 
and well-defined and typical NSC-like shapes at later pas-
sages (Fig. 1C) (hereafter referred to BSKMLT hiNSCs). 
  Although previous studies demonstrated the direct con-
version of human somatic cells into hiNSCs, the reprodu-
cibility of previous reprogramming cocktails for generat-
ing hiNSCs using human somatic cells from distinct ori-
gins has yet to be determined (18, 20), strongly suggesting 
the necessity of highly reproducible method for hiNSCs. 
Thus, we first tried to evaluate the reproducibility of our 
reprogramming factor combination (BSKM plus SV40LT) 
in hiNSC generation. For this, we introduced our factor 
combination into two lines of human fibroblasts, CRL- 
2097 human dermal fibroblasts (obtained from American 
Type Culture Collection, Manassas, VA, USA) and F134 
human adult fibroblasts (33), which are derived from dis-
tinct individuals. Similar with hFFs (Fig. 1C and 1D), 
both CRL-2097 and F134 fibroblasts could be re-
programmed into hiNSCs (Supplementary Fig. S1A and 
S1C) expressing multiple NSC markers (Supplementary 
Fig. S1B and S1D). Taken together, our data indicate that 
our reprogramming cocktail is highly robust and reprodu-
cible for generating hiNSCs from distinct genetic back-
grounds. 
  BSKMLT hiNSCs displayed the specific morphological 
characteristics of radial glial cells in the ventricular zone 
of the developing brain (Fig. 1C). To further assess the 
regional identity of BSKMLT hiNSCs, we next checked the 
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Fig. 1. Generation of hiNSCs from hFFs using BSKM with SV40LT. (A) Schematic illustration of the reprogramming procedure for generating 
hiNSCs. Morphological changes during the reprogramming period are shown. Scale bars, 100 μm. (B) Morphology of hiNSCs after 2 weeks 
of transduction. Scale bars, 100 μm. (C) Morphology of the established hiNSCs at different passages. Scale bars, 100 μm. (D) Expression 
pattern of NSC- and fibroblast-specific markers were analyzed by RT-PCR in early and later passages of hiNSCs. GAPDH was used as 
a positive control.
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Fig. 2. Comparative analysis of reprogramming potentials of distinct factor combinations. (A) The schematic illustration depicting the strategy 
for comparing the reprogramming efficiency of distinct factor combinations. (B) Time-course immunofluorescence analysis for comparing 
reprogramming potentials of distinct factor combinations. Scale bars, 100 μm. (C) Morphology of hiNSC clusters at 2 weeks after 
transduction. Scale bars, 100 μm. (D) The number of BLBP＋/MSI1＋ colonies were counted in a time-course manner. Data are presented 
as mean±SD from six independent experiments. *p＜0.05, *p＜0.01, ***p＜0.001.
expression patterns of region-specific maker genes which 
play critical roles in establishing the precise domain boun-
daries of the developing nervous system (34). Notably, the 
expression pattern of certain genes such as PAX6, BRN2, 
MSI1, PROM1, and RC1 varied among the BSKMLT 
hiNSC lines, although the pan-NSC markers such as 
SOX2, HEY2, MSI2, BLBP, CXCR4, and GLAST were 
commonly expressed (Fig. 1D, Supplementary Fig. S1B 
and S1D). These data could be explained by the hetero-
geneity of reprogrammed BSKMLT hiNSCs, which repre-
sent distinct regional identities and developmental stages 
of NSCs. Despite the heterogeneous identity of BSKMLT 
hiNSCs, all BSKMLT hiNSC lines from distinct origins 
were negative for PLZF, a transcription factor that func-
tions in early neurodevelopment and disappears in the late 
stage of neurodevelopment (35), supporting that BSKMLT 
hiNSCs more likely represent late-stage radial glial cells 
in developing brain (Fig. 1D, Supplementary Fig. S1B and 
S1D).
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Fig. 2. Continued.
Comparative analysis of reprogramming potentials of 
distinct factor combinations in hiNSC generation
  Previous studies claimed that the reprogramming effi-
ciency toward hiNSCs was less than 0.96% and the time 
required for hiNSC generation was around 20 days (up to 
35 days) (Supplementary Table S2) (15, 18, 19, 21, 22). 
Thus, to develop a highly efficient and reproducible proto-
col for hiNSC generation, we revisited the reprogramming 
potentials of previously reported hiNSC reprogramming 
cocktails by comparing the reprogramming efficiency of 
distinct factor combinations including ours. For this, we 
introduced distinct factor combinations, OSKM (15, 16, 
22), OCT4 alone (19, 20), SOX2 alone (18, 20), SOX2＋
HMGA2 (21), and BSKM plus SV40LT. In addition, to 
scale down the number of factors required for hiNSC gen-
eration, we also introduced the following combinations, 
SOX2＋KLF4＋SV40LT (SKLT), SOX2＋C-MYC＋SV40LT 
(SMLT), and SOX2＋KLF4＋C-MYC＋SV40LT (SKMLT) 
(Fig. 2A). 
  On day 2 post-infection of each combination, 5×104 
transduced cells were re-plated onto Matrigel-coated plates 
and cultured in NSCEM (Fig. 2A). For a fair comparison, 
the expression levels of each exogenous factors were de-
termined by qPCR on day 5 of transduction. The qPCR 
analysis showed that each exogenous reprogramming fac-
tor was successfully introduced and stably expressed in the 
transduced hFFs (Supplementary Fig. S2A). To perform 
an unbiased comparative analysis of direct conversion effi-
ciency using distinct combinations in a time-course man-
ner, we immunoassayed iNSC colonies using antibodies 
against NSC-specific proteins (BLBP and MSI1) and the 
numbers of BLBP＋/MSI1＋ colonies were counted every 
week for 4 weeks of reprogramming period (Fig. 2A). 
OSKM, SMLT, SKMLT, and BSKMLT groups but not others 
exhibited BLBP＋/MSI1＋ colonies with substantial mor-
phological changes after 2 weeks post infection (Fig. 2B, 
2C and Supplementary Fig. S2B). Although we found 
some BLBP＋/MSI1＋ colonies in OSKM-transduced hFFs, 
the number of BLBP＋/MSI1＋ colonies was significantly 
decreased and nearly no colony remained after 4 weeks 
(Fig. 2B and 2D), suggesting that OSKM may be in-
sufficient to stably maintain a NSC-like state in the re-
programmed cells in our experimental setting. In contrast, 
the number of both BLBP and MSI expressing colonies 
was dramatically increased in hFFs transduced with 
SMLT, SKMLT, and BSKMLT upon further passaging (Fig. 
2B and 2D). Surprisingly, we found BLBP＋/MSI1＋ colo-
nies from SKMLT transduced hFFS within the first week 
of transduction (Fig. 2B) and the colony numbers were ex-
ponentially increased in the third and fourth weeks of re-
programming (Fig. 2D). This data indicates that BRN4 
withdrawal rather facilitates the direct conversion process 
toward hiNSCs. Notably, SMLT condition in which both 
BRN4 and KLF4 were omitted also exhibited the rapid 
conversion into hiNSCs within 7 days of transduction 
(Fig. 2B), although the colony number was slightly lower 
compared with those of SKMLT and BSKMLT (Fig. 2D). 
Taken together, our time-course analysis indicates that 
both BRN4 and KLF4 are not essential for hiNSC 
generation. 
  Our time-course immunostaining analysis detects fully 
reprogrammed hiNSCs expressing both BLBP and MSI1. 
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Fig. 3. Expression pattern of NSC-specific markers during hiNSC generation. Expression pattern of NSC markers in hFFs transduced with 
distinct factor combinations was analyzed by qPCR in a time-course manner. All the values were normalized to those of non-transduced 
hFFs. Data are presented as mean±SD of triplicate values. *p＜0.05, **p＜0.01, ***p＜0.001.
Thus, it is likely that we may miss intermediate re-
programmed cells which express BLBP and MSI1 parti-
ally or only on mRNA level upon introduction of some 
reprogramming cocktails which failed to generate BLBP＋/ 
MSI1＋ colony. To exclude this possibility, we next per-
formed qPCR analysis to explore the early molecular 
changes upon the introduction of reprogramming in-
competent (OKSM, OCT4 alone, SOX2 alone, SOX2＋
HMGA2, and SV40LT alone) and competent (SMLT, 
SKMLT, and BSKMLT) factor combinations. For this, we 
introduced distinct factor combinations in hFFs and de-
termined the expression levels of endogenous NSC mark-
ers including CXCR4, PROM1, ASCL1, and SOX2 every 
week (up to 4 weeks). Consistent with our immunostain-
ing data, NSC markers were strongly activated in SMLT, 
SKMLT, and BSKMLT transduced hFFs (Fig. 3). On the 
other hand, other reprogramming incompetent cocktails 
(OSKM, OCT4 alone, SOX2 alone, SOX2＋HMGA2, and 
SV40LT alone) failed to activate NSC markers even after 
4 weeks of transduction (Fig. 3), supporting our immuno-
staining data (Fig. 2B and 2D). Collectively, our data in-
dicate that our factor combinations (SMLT, SKMLT, and 
BSKMLT) led robust and reproducible hiNSC generation, 
and SKMLT combination, the optimized factor combina-
tion in this study, exhibited the highest conversion effi-
ciency compared with those of SMLT and BSKMLT. 
hiNSCs share molecular and functional features with 
hESC-derived control NSCs
  To characterize SKMLT hiNSCs, we generated five 
hiNSC lines from three independently transduced hFFs 
with SKMLT. All the hiNSC lines displayed typical mor-
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Fig. 4. Characterization of SKMLT hiNSCs. (A) Immunofluorescence images of hESC-derived NSCs and SKMLT hiNSCs using antibodies against 
BRN2, BLBP, MSI1, and MSI2. Scale bars, 100 μm. (B) A heat map representing expression profile of genes with more than two-fold 
expression level difference between hFFs and hESC-derived NSCs. The color represents z-score for gene expression level in log2 scale. 
Clusters with red and blue bar on the left represent genes with lower and higher expression in hFFs compared to hESC-derived NSCs, 
respectively. (C, D) Differentiation potential of SKMLT hiNSCs into astrocytes (C) and neurons (D) as determined by immunocytochemistry 
with antibodies against GFAP and TUJ1, respectively, Scale bars, 100 μm. (E, F) The efficiency of differentiation into astrocytes (E) and 
neurons (F) from hESC-derived NSCs and SKMLT hiNSCs was quantified and compared via immunostaining with GFAP and TUJ1, respectively. 
Data are presented as mean±SD from eight independent experiments. N.S.: not significant.
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Fig. 4. Continued.
phology of NSCs with activation of NSC marker genes 
(Supplementary Fig. S3A and S3B). Among them, SKMLT 
hiNSC line 5 showed the strongest expression of NSC-re-
lated genes (Supplementary Fig. S3B) and thus, we se-
lected this line for the rest of analysis. Similar with hESC- 
derived NSCs, SKMLT hiNSCs exhibited the expression of 
NSC markers such as BRN2, BLBP, MSI1, and MSI2 as 
evidenced by immunocytochemistry (Fig. 4A) and they al-
so displayed the global gene expression pattern similar 
with that of hESC-derived NSCs as shown by RNA se-
quencing analysis (Fig. 4B). We also evaluate the in vitro 
differentiation potential of SKMLT hiNSCs by inducing 
differentiation into both neurons and glial cells. After two 
weeks of differentiation, SKMLT hiNSCs could differ-
entiate into both GFAP＋ astrocytes and TUJ1＋ neurons 
(Fig. 4C and 4D). SKMLT hiNSCs also exhibited a rare 
differentiation into oligodendrocytes (Supplementary Fig. 
S4A). Notably, the differentiation efficiency into each line-
age was quite similar with those of hESC-derived NSCs 
(Fig. 4E and 4F), indicating that SKMLT hiNSCs are func-
tionally comparable to hESC-derived NSCs. Finally, we 
also evaluated the in vitro differentiation potentials of 
hiNSCs into other neuronal subtypes. As a result, we 
found that SKMLT hiNSCs could differentiate into all ma-
jor neuronal subtypes, namely GABAergic, glutamatergic, 
cholinergic, and dopaminergic neurons upon the pro-
longed culture of neurons derived from SKMLT hiNSCs as 
evidenced by immunostaining using antibodies against 
GABA, Glutamate, ChAT (choline acetyltransferase), and 
TH (tyrosine hydroxylase), respectively (Supplementary 
Fig. S4B). Altogether, our data indicate that SKMLT 
hiNSCs share key molecular and functional features with 
hESC-derived NSCs and they are indeed multipotent. 
Discussion 
  Recent studies have described the generation of hiNSCs 
or induced neural progenitor cells by introducing defined 
sets of reprogramming factors (18, 21). Ring et al. (18) 
transduced single transcription factor, SOX2, into human 
fetal fibroblasts in the presence of FGF2 and EGF to gen-
erate hiNSCs. Yu et al. (21) showed that the transduction 
of an aging-related factor, HMGA2, together with SOX2 
could enhance the hiNSC generation even from the sen-
escent cells. On the other hand, it was also shown that 
the complete or partial sets of Yamanaka’s factors that are 
generally used for iPSC generation could be also employed 
for generating NSC-like cell (15, 19, 36). However, several 
technical limitations remain to be solved before trans-
lating hiNSC technology into the clinic. First, the direct 
conversion process toward hiNSCs using previous proto-
cols is an extremely inefficient (0.003 to 0.96%) and 
time-consuming process (up to 35 days) (Supplementary 
Table S1) (15, 18, 19, 21, 22, 36). Second, Yamanaka fac-
tor-mediated iNSC generation step may involve a tran-
sient activation of pluripotency network, suggesting the 
potential tumorigenic nature of Yamanaka factor-medi-
ated hiNSCs (17). 
  In contrast, BSKMLT could efficiently and reproducibly 
generate hiNSCs from multiple human somatic cell pop-
ulations with distinct origins. BSKMLT combination 
showed the much higher reprogramming efficiency com-
pared with previously described factor combinations. 
Throughout further optimization step, we could generate 
hiNSCs with either SMLT or SKMLT, indicating that both 
BRN4 and KLF4 are not essential for hiNSC generation. 
Indeed, SKMLT combination exhibited the highest re-
programming efficiency (up to 2.4%, around 80 times 
higher than OKSM) with accelerated conversion process 
(within 7 days) (Fig. 2B and 2D). This finding could be 
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also explained by the key role of BRN4 in neuronal 
differentiation. BRN4 induces the differentiation of NSCs 
into neurons in an insulin-like growth factor-1 (IGF-1)- 
dependent manner (37). This neurogenic role of BRN4 
might decrease the yield of the self-replicative hiNSC pop-
ulation during BSKMLT mediated direct conversion proc-
ess, also indicating the distinct role of BRN4 in induction 
of multipotency between human and mouse (10, 11, 25). 
  Recently, we have described that BSKM-mediated iNSC 
production in mouse is a direct process which does not 
involve a transient acquisition of pluripotency (25). Thus, 
in contrast to Yamanaka factor-mediated direct conversion 
process, our direct conversion strategy is much more reli-
able and robust in the production of transplantable hiNSCs. 
However, there are still some hurdles remained for further 
translating our technology into the clinic. First, the cel-
lular identity of transdifferentiated hiNSCs remains elu-
sive. The unclear regional identity of hiNSCs might be 
caused by the heterogeneity of the reprogrammed cells 
(38) and thus, further clonal assay (23) for clearly address-
ing the regional identity of hiNSCs is highly required to 
elaborate cellular identity of hiNSCs for future appli-
cation. Second, we observed that SV40LT is essential for 
the efficient direct conversion toward hiNSCs, resulting in 
robust and reproducible hiNSC production. However, 
SV40LT is a well-known oncogene capable of inducing 
malignant transformation of various cells. Thus, the re-
sidual expression of SV40LT or integrated viral cassettes 
encoding SV40LT should be fully eliminated in hiNSCs 
for therapeutic applications. Further efforts for inducing 
transient expression of SV40LT without transgene in-
tegration such as an episomal vector system (7, 23) and 
in vitro transcribed mRNA are required. Third, insertional 
mutagenesis caused by the viral vector may lead to the 
continuous expression of exogenous reprogramming fac-
tors and the random gene-breaking in reprogrammed iNSCs, 
potentially resulting in functional defects (39). Therefore, 
as mentioned above, a safer method should be developed 
for integration-free gene delivery of exogenous reprogram-
ing factors.
  Our study describes a novel protocol for robustly and 
reproducibly generating hiNSCs using a well-defined 
minimized gene set under specific culture conditions. 
Thus, this current protocol might be highly suitable for 
producing patient-specific hiNSCs for cell replacement 
therapy. Moreover, hiNSCs technology might be also use-
ful for the precise in vitro modeling of various neuronal 
disorders and efficient screening of drug candidates.
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